68 related articles for article (PubMed ID: 2179960)
1. Proto-oncogene activation in multistage murine hepatocarcinogenesis.
Pitot HC
Prog Clin Biol Res; 1990; 331():311-24. PubMed ID: 2179960
[No Abstract] [Full Text] [Related]
2. Proto-oncogene and gap-junction protein expression in rodent liver neoplasms.
Beer DG; Neveu MJ
Prog Clin Biol Res; 1990; 331():293-309. PubMed ID: 1969160
[No Abstract] [Full Text] [Related]
3. Alterations in the methylation status of ras oncogenes in B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Prog Clin Biol Res; 1990; 331():335-43. PubMed ID: 2179961
[No Abstract] [Full Text] [Related]
4. Genetic and epigenetic promotion of murine hepatocarcinogenesis.
Drinkwater NR; Hanigan MH; Kemp CJ
Prog Clin Biol Res; 1990; 331():163-76. PubMed ID: 2156269
[No Abstract] [Full Text] [Related]
5. Oncogenes in mouse liver tumors.
Anderson M; Stanley L; Devereux T; Reynolds S; Maronpot R
Prog Clin Biol Res; 1992; 376():187-201. PubMed ID: 1528919
[No Abstract] [Full Text] [Related]
6. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene fos expression and post-translational modification.
Barber JR; Sassone-Corsi P; Verma IM
Prog Clin Biol Res; 1988; 266():23-37. PubMed ID: 3132724
[No Abstract] [Full Text] [Related]
8. [Expression of proto-oncogenes and its role in spermatogenic cells].
Yang JL; Xu SF
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):532-5. PubMed ID: 16078675
[TBL] [Abstract][Full Text] [Related]
9. Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis.
Sakai M; Okuda A; Hatayama I; Sato K; Nishi S; Muramatsu M
Cancer Res; 1989 Oct; 49(20):5633-7. PubMed ID: 2507134
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of multistage hepatocarcinogenesis.
Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
[No Abstract] [Full Text] [Related]
11. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
Fan H
Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
[TBL] [Abstract][Full Text] [Related]
12. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
14. Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.
Rohrschneider LR; Rothwell VM; Nicola NA
Oncogene; 1989 Aug; 4(8):1015-22. PubMed ID: 2548144
[TBL] [Abstract][Full Text] [Related]
15. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
16. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
17. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
Maroulakou IG; Papas TS; Green JE
Oncogene; 1994 Jun; 9(6):1551-65. PubMed ID: 8183549
[TBL] [Abstract][Full Text] [Related]
19. [Oncogenes, antioncogenes and carcinogenesis].
Kopnin BP
Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978
[TBL] [Abstract][Full Text] [Related]
20. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
